Írland - enska - HPRA (Health Products Regulatory Authority)

viatris limited - vancomycin - powder for solution for infusion - glycopeptide antibacterials; vancomycin

Írland - enska - HPRA (Health Products Regulatory Authority)

viatris limited - vancomycin - powder for solution for infusion - glycopeptide antibacterials; vancomycin

Nýja-Sjáland - enska - Medsafe (Medicines Safety Authority)

viatris limited - lenalidomide 10mg - capsule - 10 mg - active: lenalidomide 10mg excipient: colloidal silicon dioxide croscarmellose sodium gelatin   indigo carmine iron oxide black iron oxide yellow   microcrystalline cellulose sodium stearyl fumarate starch tekprint black sw-9008 titanium dioxide   - multiple myeloma (mm) " the treatment of patients with newly diagnosed multiple myeloma who are ineligible for autologous stem cell transplantation. " the maintenance treatment of patients with newly diagnosed multiple myeloma who have undergone autologous stem cell transplantation. " in combination with dexamethasone is indicated for the treatment of multiple myeloma patients whose disease has progressed after one therapy.

Nýja-Sjáland - enska - Medsafe (Medicines Safety Authority)

viatris limited - lenalidomide 15mg - capsule - 15 mg - active: lenalidomide 15mg excipient: colloidal silicon dioxide croscarmellose sodium gelatin   microcrystalline cellulose opacode red s-1-15094 sodium stearyl fumarate starch titanium dioxide   - multiple myeloma (mm) " the treatment of patients with newly diagnosed multiple myeloma who are ineligible for autologous stem cell transplantation. " the maintenance treatment of patients with newly diagnosed multiple myeloma who have undergone autologous stem cell transplantation. " in combination with dexamethasone is indicated for the treatment of multiple myeloma patients whose disease has progressed after one therapy.

Nýja-Sjáland - enska - Medsafe (Medicines Safety Authority)

viatris limited - lenalidomide 2.5mg - capsule - 2.5 mg - active: lenalidomide 2.5mg excipient: colloidal silicon dioxide croscarmellose sodium gelatin   indigo carmine iron oxide yellow microcrystalline cellulose sodium stearyl fumarate starch tekprint black sw-9008 titanium dioxide   - multiple myeloma (mm) " the treatment of patients with newly diagnosed multiple myeloma who are ineligible for autologous stem cell transplantation. " the maintenance treatment of patients with newly diagnosed multiple myeloma who have undergone autologous stem cell transplantation. " in combination with dexamethasone is indicated for the treatment of multiple myeloma patients whose disease has progressed after one therapy.

Nýja-Sjáland - enska - Medsafe (Medicines Safety Authority)

viatris limited - lenalidomide 20mg - capsule - 20 mg - active: lenalidomide 20mg excipient: colloidal silicon dioxide croscarmellose sodium gelatin   indigo carmine iron oxide yellow microcrystalline cellulose opacode red s-1-15095 sodium stearyl fumarate starch titanium dioxide   - multiple myeloma (mm) " the treatment of patients with newly diagnosed multiple myeloma who are ineligible for autologous stem cell transplantation. " the maintenance treatment of patients with newly diagnosed multiple myeloma who have undergone autologous stem cell transplantation. " in combination with dexamethasone is indicated for the treatment of multiple myeloma patients whose disease has progressed after one therapy.

Nýja-Sjáland - enska - Medsafe (Medicines Safety Authority)

viatris limited - lenalidomide 25mg - capsule - 25 mg - active: lenalidomide 25mg excipient: colloidal silicon dioxide croscarmellose sodium gelatin   microcrystalline cellulose sodium stearyl fumarate starch tekprint black sw-9008 titanium dioxide   - multiple myeloma (mm) " the treatment of patients with newly diagnosed multiple myeloma who are ineligible for autologous stem cell transplantation. " the maintenance treatment of patients with newly diagnosed multiple myeloma who have undergone autologous stem cell transplantation. " in combination with dexamethasone is indicated for the treatment of multiple myeloma patients whose disease has progressed after one therapy.

Nýja-Sjáland - enska - Medsafe (Medicines Safety Authority)

viatris limited - lenalidomide 5mg - capsule - 5 mg - active: lenalidomide 5mg excipient: colloidal silicon dioxide croscarmellose sodium gelatin   microcrystalline cellulose sodium stearyl fumarate starch tekprint black sw-9008 titanium dioxide   - multiple myeloma (mm) " the treatment of patients with newly diagnosed multiple myeloma who are ineligible for autologous stem cell transplantation. " the maintenance treatment of patients with newly diagnosed multiple myeloma who have undergone autologous stem cell transplantation. " in combination with dexamethasone is indicated for the treatment of multiple myeloma patients whose disease has progressed after one therapy.

Nýja-Sjáland - enska - Medsafe (Medicines Safety Authority)

viatris limited - lenalidomide 7.5mg - capsule - 7.5 mg - active: lenalidomide 7.5mg excipient: colloidal silicon dioxide croscarmellose sodium gelatin   iron oxide black iron oxide yellow microcrystalline cellulose sodium stearyl fumarate starch tekprint black sw-9008 titanium dioxide   - multiple myeloma (mm) " the treatment of patients with newly diagnosed multiple myeloma who are ineligible for autologous stem cell transplantation. " the maintenance treatment of patients with newly diagnosed multiple myeloma who have undergone autologous stem cell transplantation. " in combination with dexamethasone is indicated for the treatment of multiple myeloma patients whose disease has progressed after one therapy.

Írland - enska - HPRA (Health Products Regulatory Authority)

viatris limited - valsartan - film-coated tablet - angiotensin ii antagonists, plain; valsartan